A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study

European Heart Journal

30 March 2024
Organised by: Logo
ESC Journals DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE Diseases of the Aorta Cardiovascular Surgery Interventional Cardiology VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Infective Endocarditis Valvular Heart Disease

Abstract

AbstractBackground and Aims

There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European countries.

Methods

This was a study of patients with severe symptomatic aortic stenosis (AS) undergoing TAVI with balloon-expandable valves before and after implementation of BENCHMARK best practices. Principal objectives were to reduce hospital length of stay (LoS) and duration of intensive care stay. Secondary objective was to document patient safety.

Results

Between January 2020 and March 2023, 897 patients were documented prior to and 1491 patients after the implementation of BENCHMARK practices. Patient characteristics were consistent with a known older TAVI population and only minor differences. Mean LoS was reduced from 7.7 ± 7.0 to 5.8 ± 5.6 days (median 6 vs. 4 days; P < .001). Duration of intensive care was reduced from 1.8 to 1.3 days (median 1.1 vs. 0.9 days; P < .001). Adoption of peri-procedure best practices led to increased use of local anaesthesia (96.1% vs. 84.3%; P < .001) and decreased procedure (median 47 vs. 60 min; P < .001) and intervention times (85 vs. 95 min; P < .001). Thirty-day patient safety did not appear to be compromised with no differences in all-cause mortality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening bleeding (1.3%), stage 2/3 acute kidney injury (0.7%), and valve-related readmission (1.2%).

Conclusions

Broad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.

Contributors

Derk Frank
Derk Frank

Author

University Medical Center of Schleswig-Holstein Kiel , Germany

Sandra Lauck
Sandra Lauck

Author

University of British Columbia Vancouver , Canada

Francesco Saia
Francesco Saia

Author

IRCCS University Hospital of Bologna S. Orsola Polyclinic Bologna , Italy

Carlo Di Mario
Carlo Di Mario

Author

University of Florence Florence , Italy

Joan Antoni Gómez-Hospital
Joan Antoni Gómez-Hospital

Author

University Hospital of Bellvitge Barcelona , Spain

Giuseppe Musumeci
Giuseppe Musumeci

Author

Mauriziano Umberto Hospital Turin , Italy

Nicolas Meneveau
Nicolas Meneveau

Author

Regional University Hospital Jean Minjoz Besancon , France

Federico De Marco
Federico De Marco

Author

Monzino Cardiology Centre Milan , Italy

Ferdinand Vogt
Ferdinand Vogt

Author

Artemed Specialized Clinic Munchen Munich , Germany

ESC 365 is supported by